Jinan Acetate Chemical Co., Ltd. (4763.TW)
TWD 910.0
(0.66%)
TWD 910.0
(0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.02 Billion | 4.26 Billion | 2.71 Billion | 2.35 Billion | 2.17 Billion | 1.73 Billion |
| Cost of Revenue | 4.13 Billion | 2.58 Billion | 1.89 Billion | 1.56 Billion | 1.5 Billion | 1.31 Billion |
| Gross Profit | 6.88 Billion | 1.68 Billion | 815.08 Million | 788.52 Million | 673.22 Million | 421.35 Million |
| Operating Expenses | 6.88 Billion | 606.75 Million | 462.83 Million | 289.31 Million | 282.08 Million | 259.18 Million |
| Selling, General and Administrative Expenses | 652.63 Million | 435.46 Million | 272.34 Million | 191.88 Million | 185.41 Million | 148.7 Million |
| Research and Development Expenses | 187.49 Million | 171.29 Million | 190.48 Million | 97.42 Million | 96.67 Million | 110.48 Million |
| Other Expenses | - | 13.98 Million | 28.04 Million | 48.45 Million | 10.56 Million | 64.66 Million |
| Cost and Expenses | 4.97 Billion | 3.19 Billion | 2.36 Billion | 1.85 Billion | 1.78 Billion | 1.57 Billion |
| Operating Income | 6.04 Billion | 1.19 Billion | 353.98 Million | 523.08 Million | 401.7 Million | 162.16 Million |
| Interest Expense | 18.19 Million | 34.2 Million | 35.07 Million | 25.86 Million | 23.34 Million | 16.78 Million |
| Income Tax Expense | 913.17 Million | 139.47 Million | 5.24 Million | 43.26 Million | 47.1 Million | -14.03 Million |
| Earnings before Tax | 6.13 Billion | 1.41 Billion | 365.44 Million | 552.85 Million | 378.36 Million | 210.05 Million |
| Net Income | 5.17 Billion | 1.24 Billion | 357.5 Million | 504.55 Million | 329.67 Million | 225.09 Million |
| Earnings Per Share Basic | 54.40 | 17.84 | 5.35 | 7.52 | 4.87 | 3.29 |
| Earnings Per Share Diluted | 62.13 | 15.44 | 4.57 | 7.37 | 4.78 | 3.09 |
| Weighted Average Shares Outstanding | 95.18 Million | 70.06 Million | 66.78 Million | 67.05 Million | 67.65 Million | 68.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 83.34 Million | 84.06 Million | 78.39 Million | 73.25 Million | 72.39 Million | 72.94 Million |
| Gross Margin | 0.62 | 0.39 | 0.30 | 0.34 | 0.31 | 0.24 |
| EBIT Margin | 0.58 | 0.32 | 0.18 | 0.27 | 0.23 | 0.18 |
| Profit Margin | 0.47 | 0.29 | 0.13 | 0.21 | 0.15 | 0.13 |
| EBITDA | 6.43 Billion | 1.62 Billion | 535.08 Million | 684.08 Million | 499.93 Million | 315.94 Million |
| Earnings Before Tax Margin | 0.55 | 0.28 | 0.13 | 0.22 | 0.18 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.19 Billion | 3.61 Billion | 11.02 Billion | 3.83 Billion | 3.26 Billion | 2.36 Billion |
| Cost of Revenue | 1.23 Billion | 1.18 Billion | 4.13 Billion | 1.25 Billion | 1.23 Billion | 931.6 Million |
| Gross Profit | 1.95 Billion | 2.42 Billion | 6.88 Billion | 2.58 Billion | 2.02 Billion | 1.43 Billion |
| Operating Expenses | 2.63 Billion | 196.59 Million | 840.12 Million | 250.36 Million | 214.21 Million | 171.1 Million |
| Selling, General and Administrative Expenses | 129.72 Million | 136.24 Million | - | 156.65 Million | 180.37 Million | 146.29 Million |
| Research and Development Expenses | 76.74 Million | 60.34 Million | - | 93.71 Million | 33.83 Million | 24.81 Million |
| Other Expenses | -2.63 Billion | 27.71 Million | -840.12 Million | -250.36 Million | 4.12 Million | 7.76 Million |
| Cost and Expenses | 3.87 Billion | 1.38 Billion | 4.97 Billion | 1.5 Billion | 1.45 Billion | 1.1 Billion |
| Operating Income | -675.24 Million | 2.22 Billion | 6.04 Billion | 2.33 Billion | 1.87 Billion | 1.36 Billion |
| Interest Expense | 3000.00 | - | 18.19 Million | 73 Thousand | 3.99 Million | 6.44 Million |
| Income Tax Expense | 255.09 Million | 326.55 Million | 913.17 Million | 332.85 Million | 210.48 Million | 268.05 Million |
| Earnings before Tax | 2.03 Billion | 2.43 Billion | 6.13 Billion | 2.27 Billion | 1.86 Billion | 1.35 Billion |
| Net Income | 1.75 Billion | 2.1 Billion | 5.17 Billion | 1.93 Billion | 1.63 Billion | 1.07 Billion |
| Earnings Per Share Basic | 20.75 | 24.48 | - | 22.90 | 17.27 | 13.13 |
| Earnings Per Share Diluted | 20.74 | 24.46 | - | 22.74 | 17.20 | 13.05 |
| Weighted Average Shares Outstanding | 85.9 Million | 85.9 Million | 82.78 Million | 84.54 Million | 94.95 Million | 82.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 85.97 Million | 85.97 Million | 83.34 Million | 85.13 Million | 95.33 Million | 82.68 Million |
| Gross Margin | 0.61 | 0.67 | 0.62 | 0.67 | 0.62 | 0.61 |
| EBIT Margin | -0.21 | 0.65 | - | 0.61 | 0.61 | 0.60 |
| Profit Margin | 0.55 | 0.58 | 0.47 | 0.50 | 0.50 | 0.46 |
| EBITDA | -675.24 Million | 2.35 Billion | - | 2.33 Billion | 1.98 Billion | 1.42 Billion |
| Earnings Before Tax Margin | -0.21 | 0.62 | 0.55 | 0.61 | 0.57 | 0.58 |
MED
ICGUF
4951
0907
AJ-R
EXS